跳至主要内容
临床试验/NCT02609269
NCT02609269Enrolling By Invitation不适用

Prospective Expression Analysis Using The Decipher Genomics Resource for Intelligent Discovery (GRID)® and Data Sharing Program

GenomeDx Biosciences Corp0 个研究点目标入组 1,000,000 人开始时间: 2015年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
1,000,000
主要终点
Link complete genomic RNA expression array data generated from Decipher testing with clinical data for patients who consent to participate.

研究概览

简要总结

To prospectively evaluate the utility of genomic expression data and whole slide digital pathology image data as a tool to better characterize the tumors of individual patients, and to understand how genomic and histologic information from individual patients undergoing routine clinical testing can be used in population-level analysis to improve treatment and outcomes.

详细描述

Observational study involving the release of tumor genome-wide expression and whole slide imaging data generated by the Decipher assay which will be linked to clinical treatment and outcome data for patients in whom Decipher clinical testing was performed. The GRID database population will be used to characterize the genomics and histopathologic features of cancer and discover or validate gene expression signatures as well as digital pathology models that may be useful for understanding of the biology of the disease and implementing precision medicine approaches for cancer patients.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Subjects that have had a Decipher clinical test

排除标准

  • 未提供

结局指标

主要结局

Link complete genomic RNA expression array data generated from Decipher testing with clinical data for patients who consent to participate.

时间窗: Through study completion, an average of 1 year

Role of genomic expression data in the biology of certain cancers

次要结局

未报告次要终点

研究者

发起方
GenomeDx Biosciences Corp
申办方类型
Industry
责任方
Sponsor

相似试验